Linear growth in preschool children treated with mass azithromycin distributions for trachoma: A cluster-randomized trial.

Linear growth in preschool children treated with mass azithromycin distributions for trachoma: A cluster-randomized trial.

<h4>Background</h4>Mass azithromycin distributions have been shown to reduce mortality among pre-school children in sub-Saharan Africa. It is unclear what mediates this mortality reduction, but one possibility is that antibiotics function as growth promoters for young children.<h4>...

Full description

Bibliographic Details
Main Authors:	Jeremy D Keenan, Sintayehu Gebresillasie, Nicole E Stoller, Berhan A Haile, Zerihun Tadesse, Sun Y Cotter, Kathryn J Ray, Kristen Aiemjoy, Travis C Porco, E Kelly Callahan, Paul M Emerson, Thomas M Lietman
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2019-06-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	https://doi.org/10.1371/journal.pntd.0007442

Similar Items

Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
by: Jeremy D Keenan, et al.
Published: (2018-08-01)

A randomized trial of two coverage targets for mass treatment with azithromycin for trachoma.
by: Sheila K West, et al.
Published: (2013-01-01)

The efficacy of oral azithromycin in clearing ocular chlamydia: Mathematical modeling from a community-randomized trachoma trial
by: Fengchen Liu, et al.
Published: (2014-03-01)

Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma
by: Abdou Amza, et al.
Published: (2021-01-01)

Sensitivity and specificity of computer vision classification of eyelid photographs for programmatic trachoma assessment.
by: Matthew C Kim, et al.
Published: (2019-01-01)

Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia.
by: Tigist Astale, et al.
Published: (2018-02-01)

Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger.
by: Jessica S Kim, et al.
Published: (2019-01-01)

Identifying a sufficient core group for trachoma transmission.
by: Thomas M Lietman, et al.
Published: (2018-10-01)

'If an Eye Is Washed Properly, It Means It Would See Clearly': A Mixed Methods Study of Face Washing Knowledge, Attitudes, and Behaviors in Rural Ethiopia.
by: Kristen Aiemjoy, et al.
Published: (2016-10-01)

Prevalence of trachoma at sub-district level in ethiopia: determining when to stop mass azithromycin distribution.
by: Jonathan D King, et al.
Published: (2014-03-01)

Stopping azithromycin mass drug administration for trachoma: A systematic review.
by: Hamidah Mahmud, et al.
Published: (2021-07-01)

Reliability of trachoma clinical grading--assessing grading of marginal cases.
by: Salman A Rahman, et al.
Published: (2014-05-01)

Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
by: Kevin Cyrus Hong, et al.
Published: (2009-07-01)

The distribution of the prevalence of ocular chlamydial infection in communities where trachoma is disappearing
by: Thomas M. Lietman, et al.
Published: (2015-06-01)

Risk factors for ocular chlamydia after three mass azithromycin distributions.
by: Berhan Ayele, et al.
Published: (2011-12-01)

The distribution of ocular Chlamydia prevalence across Tanzanian communities where trachoma is declining.
by: Salman A Rahman, et al.
Published: (2015-03-01)

Probabilistic forecasts of trachoma transmission at the district level: A statistical model comparison
by: Amy Pinsent, et al.
Published: (2017-03-01)

Mass treatment with azithromycin for trachoma control: participation clusters in households.
by: Elizabeth N Ssemanda, et al.
Published: (2010-10-01)

Antibiotic Resistance in Streptococcus pneumoniae after Azithromycin Distribution for Trachoma
by: Derek K-H. Ho, et al.
Published: (2015-01-01)

Correction: The Distribution of Ocular Chlamydia Prevalence across Tanzanian Communities Where Trachoma Is Declining.
by: Salman A Rahman, et al.
Published: (2015-05-01)

Association between ocular bacterial carriage and follicular trachoma following mass azithromycin distribution in The Gambia.
by: Sarah E Burr, et al.
Published: (2013-01-01)

Trachoma and Relative Poverty: A Case-Control Study.
by: Esmael Habtamu, et al.
Published: (2015-11-01)

When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries.
by: Kathryn J Ray, et al.
Published: (2009-06-01)

Impact of Community Mass Treatment with Azithromycin for Trachoma Elimination on the Prevalence of Yaws.
by: Michael Marks, et al.
Published: (2015-01-01)

Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia.
by: Emma M Harding-Esch, et al.
Published: (2013-01-01)

Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity.
by: Fengchen Liu, et al.
Published: (2013-01-01)

Importance of coverage and endemicity on the return of infectious trachoma after a single mass antibiotic distribution.
by: Takele Lakew, et al.
Published: (2009-08-01)

Correction: Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia.
by: Emma M. Harding-Esch, et al.
Published: (2013-06-01)

Correction: Assessment of Transmission in Trachoma Programs over Time Suggests No Short-Term Loss of Immunity
by: Fengchen Liu, et al.
Published: (2013-07-01)

Correction: Assessment of Transmission in Trachoma Programs over Time Suggests No Short-Term Loss of Immunity.
by: Fengchen Liu, et al.
Published: (2013-07-01)

Non-participation during azithromycin mass treatment for trachoma in The Gambia: heterogeneity and risk factors.
by: Tansy Edwards, et al.
Published: (2014-08-01)

A rationale for continuing mass antibiotic distributions for trachoma
by: House Jenafir, et al.
Published: (2007-08-01)

Correction: Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia
by: Emma M. Harding-Esch, et al.
Published: (2013-06-01)

Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma Program.
by: Bidya Prasad Pant, et al.
Published: (2016-02-01)

Does mass azithromycin distribution impact child growth and nutrition in Niger? A cluster-randomized trial.
by: Abdou Amza, et al.
Published: (2014-09-01)

Safety of azithromycin in infants under six months of age in Niger: A community randomized trial.
by: Catherine E Oldenburg, et al.
Published: (2018-11-01)

Short-term Forecasting of the Prevalence of Trachoma: Expert Opinion, Statistical Regression, versus Transmission Models.
by: Fengchen Liu, et al.
Published: (2015-08-01)

Correction: Short-term Forecasting of the Prevalence of Trachoma: Expert Opinion, Statistical Regression, versus Transmission Models.
by: Fengchen Liu, et al.
Published: (2015-09-01)

Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial
by: Catherine E. Oldenburg, et al.
Published: (2019-12-01)

Short-Term Malaria Reduction by Single-Dose Azithromycin during Mass Drug Administration for Trachoma, Tanzania
by: Stephen E. Schachterle, et al.
Published: (2014-06-01)

Cannot write session to /tmp/vufind_sessions/sess_c9d2gqie0q56ie0mpla5e9mcg2